Company Description
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan.
It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products.
This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation.
The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools.
The company’s products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services.
It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs.
The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006.
The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
| Country | United States |
| Founded | 2005 |
| Industry | Specialty Industrial Machinery |
| Sector | Industrials |
| Employees | 3,000 |
| CEO | Thomas Logan |
Contact Details
Address: 1218 Menlo Drive Atlanta, Georgia 30318 United States | |
| Phone | 770 432 2744 |
| Website | mirion.com |
Stock Details
| Ticker Symbol | MIR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001809987 |
| CUSIP Number | 60471A101 |
| ISIN Number | US60471A1016 |
| Employer ID | 83-0974996 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Thomas D. Logan | Founder, Medical Group President, Chief Executive Officer and Director |
| Brian Schopfer | Chief Financial Officer |
| Loic Eloy | Group President of Technologies |
| Christopher Moore CPA | Chief Accounting Officer and Principal Accounting Officer |
| James Cocks | Chief Technology Officer |
| Erin Schesny | Chief Marketing Officer |
| Alison Ulrich | Chief Human Resources Officer |
| Shelia Webb | Chief Digital Officer |
| Mark Siviter | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Nov 6, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Oct 30, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | 8-K | Current Report |
| Oct 24, 2024 | 144 | Filing |
| Sep 25, 2024 | 144 | Filing |
| Sep 24, 2024 | 144 | Filing |
| Aug 23, 2024 | 144 | Filing |
| Aug 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |